News

University of Queensland researchers have found a genetic mutation that causes melanoma can lie dormant in healthy skin, a finding that could improve screening of areas more prone to the disease.

People with the most common form of lung cancer could receive more effective, individualised treatment after University of Queensland researchers developed a way to predict how cancer cells will respond to different therapies.

Researchers from the University of Queensland and University of Cambridge have developed a platform for human cells powered by artificial intelligence that could aid the development of therapeutics and personalised treatments for cancer patients.

People living in areas of lower socio-economic advantage are significantly more likely to be diagnosed with a more advanced stage melanoma than those in more affluent areas, University of Queensland researchers have found.

A team of microbiologists and immunologists has completed the first steps towards developing a universal vaccine against Group A Streptococcus (Strep-A).

University of Queensland researchers have been the first in the world to successfully grow fully functioning human skin in a laboratory.

Gut bacteria plays a key role in triggering several chronic inflammatory rheumatic diseases affecting the spine and joints, a University of Queensland study has found.

Researchers at The University of Queensland have dosed 5 participants in the first clinical trial of a potentially revolutionary immunotherapy drug to treat Type 1 diabetes.

Researchers at The University of Queensland have found improving the function of the gut microbiome may delay the onset of type 1 diabetes (T1D).

University of Queensland researchers have discovered immunotherapy, when used to treat people with advanced cancers, also helps reduce sunspots and skin cancers by at least 65 per cent.

University of Queensland research using "natural killer" cells may lead to the first new treatment for a devastating childhood cancer in 40 years.

University of Queensland (UQ) researcher Dr Debottam Sinha has received $450,000 from the Passe & Williams Foundation to improve health outcomes for patients with a rare form of cancer.

University of Queensland researchers have received a Ramaciotti Health Investment Grant for investigating precision medicine for head and neck cancer.

Researchers at The University of Queensland are developing a comprehensive paediatric immune cell ‘atlas’ to aid in the diagnosis and treatment of children with life-threatening diseases such as cancer, diabetes and lupus.

Teams of researchers from The University of Queensland working on pioneering melanoma imaging and preventing deadly infections, along with a science engagement team, have won prestigious 2024 Australian Museum Eureka Prizes.

Long term relief is within reach for people with the debilitating autoimmune disease, Rheumatoid Arthritis (RA), after an $11.5 million grant was awarded to a University of Queensland-led team.

A bioscience startup and a world-leading immunologist at The University of Queensland are among the winners in the Life Sciences Queensland (LSQ) GENE Awards.

University of Queensland research could lead to a more effective immunotherapy treatment against bladder cancer.

Two teams of researchers and a science engagement team from The University of Queensland are finalists in the prestigious 2024 Australian Museum Eureka Prizes, honouring excellence in scientific discovery, invention, communication and innovation.

UQ researchers have discovered a key molecular regulator for specialised white blood cells (known as innate lymphoid cells), found in the lung.